Sg Americas Securities, LLC Argenx Se Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Argenx Se stock. As of the latest transaction made, Sg Americas Securities, LLC holds 358 shares of ARGX stock, worth $231,765. This represents 0.0% of its overall portfolio holdings.

Number of Shares

358

Previous 337 6.23%

Holding current value

$231,765

Previous $183,000 20.22%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$520.52 - $638.33 $10,930 - $13,404	21 Added 6.23%	358 $220,000
Q3 2024 Oct 03, 2024	SELL	$434.22 - $551.9 $1.16 Million - $1.47 Million	-2,662 Reduced 88.76%	337 $183,000
Q2 2024 Jul 12, 2024	BUY	$356.01 - $451.55 $100,750 - $127,788	283 Added 10.42%	2,999 $1.29 Million
Q1 2024 May 06, 2024	SELL	$356.95 - $413.29 $2.29 Million - $2.65 Million	-6,402 Reduced 70.21%	2,716 $1.07 Million
Q4 2023 Jan 12, 2024	SELL	$338.91 - $506.01 $1.33 Million - $1.99 Million	-3,933 Reduced 30.14%	9,118 $3.47 Million
Q3 2023 Oct 13, 2023	SELL	$369.35 - $548.43 $2.24 Million - $3.33 Million	-6,065 Reduced 31.73%	13,051 $6.42 Million
Q2 2023 Jul 10, 2023	BUY	$360.14 - $422.58 $919,437 - $1.08 Million	2,553 Added 15.41%	19,116 $7.45 Million
Q1 2023 Apr 28, 2023	SELL	$334.23 - $403.65 $651,080 - $786,310	-1,948 Reduced 10.52%	16,563 $6.17 Million
Q4 2022 Feb 02, 2023	BUY	$342.17 - $402.31 $3.57 Million - $4.2 Million	10,440 Added 129.35%	18,511 $7.01 Million
Q3 2022 Oct 31, 2022	SELL	$343.2 - $395.75 $5.12 Million - $5.9 Million	-14,908 Reduced 64.88%	8,071 $2.85 Million
Q2 2022 Jul 29, 2022	BUY	$269.58 - $378.88 $341,827 - $480,419	1,268 Added 5.84%	22,979 $8.71 Million
Q1 2022 Apr 29, 2022	SELL	$254.45 - $351.06 $3.65 Million - $5.03 Million	-14,338 Reduced 39.77%	21,711 $6.85 Million
Q4 2021 Feb 07, 2022	BUY	$272.01 - $353.03 $877,776 - $1.14 Million	3,227 Added 9.83%	36,049 $12.6 Million
Q3 2021 Nov 01, 2021	BUY	$295.0 - $350.58 $226,855 - $269,596	769 Added 2.4%	32,822 $9.91 Million
Q2 2021 Aug 12, 2021	BUY	$257.11 - $319.92 $471,539 - $586,733	1,834 Added 6.07%	32,053 $9.65 Million
Q1 2021 May 13, 2021	BUY	$268.3 - $380.31 $5.87 Million - $8.32 Million	21,871 Added 261.99%	30,219 $8.32 Million
Q4 2020 Feb 04, 2021	BUY	$248.13 - $308.36 $1.8 Million - $2.24 Million	7,264 Added 670.11%	8,348 $2.46 Million
Q3 2020 Nov 09, 2020	BUY	$215.51 - $272.51 $84,695 - $107,096	393 Added 56.87%	1,084 $285,000
Q2 2020 Jul 20, 2020	BUY	$127.44 - $232.72 $88,061 - $160,809	691 New	691 $156,000
Q1 2020 Apr 30, 2020	SELL	$108.83 - $165.23 $124,936 - $189,684	-1,148 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$106.59 - $164.21 $122,365 - $188,513	1,148 New	1,148 $184,000
Q3 2019 Nov 04, 2019	SELL	$113.31 - $150.51 $96,200 - $127,782	-849 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$115.0 - $141.58 $26,220 - $32,280	-228 Reduced 21.17%	849 $120,000
Q1 2019 Apr 29, 2019	BUY	$98.85 - $134.59 $106,461 - $144,953	1,077 New	1,077 $134,000

Others Institutions Holding ARGX

# of Institutions

405

Shares Held

30.8M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Argenx Se Transaction History